|

T3011 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • ImmVira Pharma Co. Ltd2

Indications

  • Cancer2
  • Nonmuscle-invasive Bladder Cancer1
  • Squamous Cell Carcinoma1
  • HNSCC1
  • Sarcoma1

Gilbert, Arizona1 trial

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

Banner MD Anderson Cancer Center

Phase 1/2

Queen Creek, Arizona1 trial

A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC

East Valley Urology Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.